ANVISA-Brazil has completed inspection at Caplin Point Laboratories’ subsidiary -- Caplin Steriles’ injectable and ophthalmic manufacturing facility located at Gummidipoondi. The inspection was conducted between August 12 and 16, 2024 and concluded with zero observations.
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.